rFVIIIFc for first-time immune tolerance induction (ITI) therapy: interim results from the global, prospective verITI-8 study

Lynn Malec1,a, Manuel Carcao2, Nisha Jain3, Mariya Spasova4, Dobrin Konstantinov5, Neha...

Read More